Shire Owes $45M Milestone After Life Science Acquisition
Pharmaceutical company Shire owes $45 million in a post-merger milestone payment to the shareholders of a life science company it acquired in 2012, the Delaware Chancery Court found on Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article